ANTIBODY MEDIATED REJECTION

Clinical trials for ANTIBODY MEDIATED REJECTION explained in plain language.

Never miss a new study

Get alerted when new ANTIBODY MEDIATED REJECTION trials appear

Sign up with your email to follow new studies for ANTIBODY MEDIATED REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 6 Completed 3

New drug aims to stop kidney transplant rejection

Disease control Recruiting now

This study tests a new medicine called CID-103 in adults whose kidney transplants are being rejected by their immune system (antibody-mediated rejection). The trial has two parts: first, to find a safe dose, and second, to see if the drug can stop the rejection. About 58 people w…

Matched conditions: ANTIBODY MEDIATED REJECTION

Phase: PHASE1, PHASE2 • Sponsor: CASI pharmaceuticals, Inc. • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC

ANTIBODY MEDIATED REJECTION

Get alerted when new ANTIBODY MEDIATED REJECTION trials appear

New drug aims to stop kidney transplant rejection